Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Immacule Lifesciences is a specialized Contract Development and Manufacturing Organization (CDMO) focused on sterile injectable dosage forms. Based in India, the company operates a state-of-the-art manufacturing facility in Himachal Pradesh that adheres to international regulatory standards such as USFDA and EU-GMP. They offer a comprehensive suite of services including formulation development, analytical method development, and commercial-scale production of liquid and lyophilized vials. Immacule's portfolio primarily targets complex generics in therapeutic areas like oncology and critical care, serving pharmaceutical partners worldwide. The company is recognized for its expertise in lyophilization technology and its ability to handle high-potency compounds. By providing end-to-end solutions, Immacule enables its partners to bring high-quality injectable medicines to global markets efficiently.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Immacule Lifesciences.